Clinical trial
Levetiracetam Treatment of L-dopa Induced Dyskinesias
NCT00076674 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00076674 |
|---|---|
| Title | Levetiracetam Treatment of L-dopa Induced Dyskinesias |
| Official title | Levetiracetam Treatment of L-dopa Induced Dyskinesias |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dyskinesias, Parkinson Disease |
| Intervention type | Drug |
| Interventions | Intravenous Levodopa |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Completion | Oct 1, 2005 |
| First posted | Jan 29, 2004 |
| Last update posted | Sep 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: